HCW Biologics Inc. Common Stock

HCWBNASDAQ • USD
ThemeBiotech - Drug Development›Immunology & Autoimmune
4.30 USD
↘ 0.20 (4.44%)AT CLOSE (11:59 AM EDT)
4.23
↘ 0.07 (1.65%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
4.23
↘ 0.07 (1.65%)
🔴Market: CLOSED

HCW Biologics Inc. Common Stock (HCWB) trades at $4.30 per share. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, HCWB appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Jul 15, 2026.

Open?$4.42
High?$4.50
Low?$4.30
Prev. Close?$4.50
Volume?45.2K
Avg. Volume?841.2K
VWAP?$4.35
Rel. Volume?0.05x
Bid / Ask
Bid?$3.68 × 100
Ask?$5.13 × 100
Spread?$1.45
Midpoint?$4.41
Valuation & Ratios
Market Cap?7.2M
Shares Out?1.6M
Float?6.1M
Float %?90.7%
P/E Ratio?N/A
P/B Ratio?1.25
EPS?-$11.35
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
Themes
Biotech - Drug Development›Immunology & AutoimmuneLongevity & Aging›Age-Related Therapeutics
Employees
35
Market Cap
7.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.hcwbiologics.com
Listed
2021-07-20
Address
2929 N COMMERCE PKWY
MIRAMAR, FL 33025
Phone: 954-842-2024
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
77
Z-Score?
0
Momentum?
90
Short Sent.?
100
Piotroski F-Score?6/9Mixed
Altman Z-Score?-6.70Distress
Confidence?46%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?0.68%Low
Short Interest?41.7K
Days to Cover?1.0
Free Float6.1M
Avg Daily Volume197.6K
Settlement Date2026-06-30
Financial Health
Current Ratio?0.09Weak
Quick Ratio?0.09Weak
Cash Ratio?0.06Low
Debt/Equity?1.14Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
92
1.25CHEAP▾
P/S?
Peers
100
S&P
85
1.09CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.7CHEAP▾
EV/Sales?
Peers
100
S&P
77
1.90CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-314.4%WEAK▾
ROA?
S&P
3
-66.3%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$12.5M
Fundamentals ratios updated end of day
MarketsMoversWatchlist